Feasibility study of patient-specific quality assurance system for high-dose-rate brachytherapy in patients with cervical cancer

Boram Lee, Sung Hwan Ahn, Hyeyoung Kim, Youngyih Han, Seung Jae Huh, Jin Sung Kim, Dong Wook Kim, Jina Sim, Myonggeun Yoon

Research output: Contribution to journalArticlepeer-review


This study was conducted for the purpose of establishing a quality-assurance (QA) system for brachytherapy that can ensure patient-specific QA by enhancing dosimetric accuracy for the patient’s therapy plan. To measure the point-absorbed dose and the 2D dose distribution for the patient’s therapy plan, we fabricated a solid phantom that allowed for the insertion of an applicator for patient-specific QA and used an ion chamber and a film as measuring devices. The patient treatment plan was exported to the QA dose-calculation software, which calculated the time weight of dwell position stored in the plan DICOM (Digital Imaging and Communications in Medicine) file to obtain an overall beam quality correction factor, and that correction was applied to the dose calculations. Experiments were conducted after importing the patient’s treatment planning source data for the fabricated phantom and inserting the applicator, ion chamber, and film into the phantom. On completion of dose delivery, the doses to the ion chamber and film were checked against the corresponding treatment plan to evaluate the dosimetric accuracy. For experimental purposes, five treatment plans were randomly selected. The beam quality correction factors for ovoid and tandem brachytherapy applicators were found to be 1.15 and 1.10 − 1.12, respectively. The beam quality correction factor in tandem fluctuated by approximately 2%, depending on the changes in the dwell position. The doses measured by using the ion chamber showed differences ranging from −2.4% to 0.6%, compared to the planned doses. As for the film, the passing rate was 90% or higher when assessed using a gamma value of the local dose difference of 3% and a distance to agreement of 3 mm. The results show that the self-fabricated phantom was suitable for QA in clinical settings. The proposed patient-specific QA for the treatment planning is expected to contribute to reduce dosimetric errors in brachytherapy and, thus, to enhancing treatment accuracy.

Original languageEnglish
Pages (from-to)1029-1036
Number of pages8
JournalJournal of the Korean Physical Society
Issue number8
Publication statusPublished - 2016 Apr 1


  • Applicator
  • Brachytherapy
  • Patient-specific QA
  • Phantom

ASJC Scopus subject areas

  • Physics and Astronomy(all)


Dive into the research topics of 'Feasibility study of patient-specific quality assurance system for high-dose-rate brachytherapy in patients with cervical cancer'. Together they form a unique fingerprint.

Cite this